Oxford Biolabs Limited

Oxford Biolabs Limited, based in Oxford, UK, is a small, active company founded fifteen years ago in 2009. With £1,298,068 in assets and a real address at The Oxford Science Park, it’s a solo-founded operation managed by a single director and owner. The company boasts a stellar 5.0 Google rating from fourteen reviews, and regularly imports essential oils and perfumes, with the latest import activity recorded just last month.

Oxford Biolabs operates in the research and experimental development sector, specializing in natural sciences and engineering. Its website showcases a range of products focused on hair support, skin rejuvenation, and immune system enhancement. The site emphasizes science-backed solutions, with a particular focus on hair loss and greying—offering products like TRX2 capsules, lotions, and shampoos alongside more specialized treatments. The company also runs an e-commerce site, selling directly to consumers.

Financially, Oxford Biolabs presents a mixed picture. Cash bank holdings increased by a healthy 25% to £770,000, indicating strong liquidity. However, creditors have risen dramatically by 310% to £160,000, suggesting increased reliance on short-term borrowing. Trade debtors decreased by 33% to £150,000, which could be a positive sign of improved collections. Net assets remained steady at £1,100,000, a 7% increase. The company's small size (meeting two of three conditions for being a small company) allows for agility, but the significant increase in creditors is something to watch. No auditor is mentioned, likely due to the company's exemption as a small entity. The company’s long-term stability will depend on managing its debt and continuing to innovate in its niche market.

Registered in England/Wales under the registration number 07028185, with a registered address at OX4 4GA, United Kingdom, Oxford, Oxfordshire, Magdalen Centre, The Oxford Science Park, Robert Robinson Avenue.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.